SecBot SecBot

340B PATIENTS Act of 2024

S. 5021 Sen. Peter Welch (D-VT) In committee
Bill text PDF
  1. Introduced Sep 11
  2. Committee Sep 11
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Sep 11, 2024Next: Senate vote
777d ago Sep 11, 2024: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 2 filings
Subscribe to see spend
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Biotech & Pharma 2
Search all 2 companies, their asks and price moves Subscribe

Summary

This bill clarifies that drug manufacturers participating in the 340B drug discount program must offer discounted prices to covered entities regardless of how or where the drug is dispensed, and cannot place conditions on a covered entity's ability to purchase or use drugs at the discounted price, including through contract pharmacies. It also establishes new penalties for manufacturers that violate these requirements.

Summary of the bill text as introduced in Senate (Sep 11, 2024), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.